Platelet Transfusion Practices in the ICU: A Prospective Multicenter Cohort Study
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie
PubMed
41002230
PubMed Central
PMC12655871
DOI
10.1097/ccm.0000000000006880
PII: 00003246-990000000-00632
Knihovny.cz E-zdroje
- Klíčová slova
- intensive care unit, platelet, thresholds, thrombocytopenia, transfusion,
- MeSH
- dospělí MeSH
- jednotky intenzivní péče * statistika a číselné údaje MeSH
- krvácení terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- počet trombocytů MeSH
- prospektivní studie MeSH
- senioři MeSH
- transfuze trombocytů * statistika a číselné údaje normy metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
OBJECTIVE: There is a lack of comprehensive international data regarding platelet transfusion practices in the ICU. This study aimed to evaluate the current occurrence rate of platelet transfusion in the ICU and provide an overview of platelet transfusion practices including indications for a platelet transfusion, thresholds, (non-)adherence and geo-economic region variations. DESIGN: International prospective cohort study. SETTING: Two hundred thirty-three centers in 30 countries worldwide. PATIENTS: All patients 18 years old and older, admitted to the ICU during a single study week, selected by each site from one of the 16 predefined weeks (March 2019 to October 2022), were included. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of the 3643 patients, 208 (6%) received a platelet transfusion during their ICU stay and main indications consisted of active bleeding (42%, n = 187/443), prophylaxis (33%, n = 144/443) or an upcoming procedure (12%, n = 51/443). The median platelet count before transfusion was 44 × 10 9 /L (interquartile range [IQR], 20-78) with variation by indication, including a higher median of 60 × 10 9 /L (IQR 31-93) during active bleeding. A threshold for transfusion was stated in 51% ( n = 224/443) of the events, with a median threshold platelet count of 50 × 10 9 /L (IQR, 40-100). The advised threshold was not adhered to in 16% ( n = 36/224) of cases, with the majority having active bleeding as indication. Contrasts in transfusion practices were observed across different geo-economic regions. Platelet transfusions were administered to 6% ( n = 156/2520) of patients in high-income countries, 5% ( n = 52/1069) of patients in upper-middle-income countries and in none from lower-middle-income countries ( n = 0/54). Non-adherence was higher in the high-income countries (23%, n = 34/149) than upper-middle-income countries (3%, n = 2/75). CONCLUSIONS: Platelet transfusions were administered to a small proportion of critically ill patients, and were given to treat active bleeding or as prophylaxis in the majority of cases. Occurence rate, indication and threshold adherence for platelet transfusion widely varied between geo-economic regions.
Department of Anesthesia and Intensive Care Military Medical Academy Belgrade Belgrade Serbia
Department of Anesthesiology Aga Khan University Hospital Nairobi Kenya
Department of Anesthesiology Amsterdam University Medical Centers Amsterdam The Netherlands
Department of Anesthesiology and Intensive Care IRCCS Humanitas Research Hospital Milan Italy
Department of Anesthesiology University Medical Center Groningen Groningen The Netherlands
Department of Cardiothoracic Surgery European Interbalkan Medical Center Thessaloniki Greece
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Clinical Science and Education Södersjukhuset Karolinska Institutet Stockholm Sweden
Department of Critical Care Asgar Ali Hospital Dhaka Bangladesh
Department of Intensive Care Adults Erasmus MC University Medical Centers Rotterdam The Netherlands
Department of Intensive Care Amsterdam University Medical Centers Amsterdam The Netherlands
Department of Intensive Care Pontificia Universidad Católica de Chile Santiago Chile
Department of Pulmonary and Critical Care New York University and Columbia University New York NY
Faculty of Medicine University of Tripoli Tripoli Libya
Intensive Care Center University Medical Center Utrecht Utrecht The Netherlands
Intensive Care Service Hospital Universitario La Paz Madrid Spain
Médecine Intensive Réanimation CHU de Brest Université de Bretagne Occidentale Brest France
Nuffield Department of Clinical Neurosciences University of Oxford Oxford United Kingdom
School of Public Health and Preventive Medicine Monash University Melbourne VIC Australia
Unidad de Cuidados Intensivos Hospital Vicente Corral Moscoso Cuenca Ecuador
Zobrazit více v PubMed
Maier CL, Stanworth SJ, Sola-Visner M, et al. : Prophylactic platelet transfusion: Is there evidence of benefit, harm, or no effect? Transfus Med Rev. 2023; 37:150751. PubMed
Stanworth SJ, Shah A: How I use platelet transfusions. Blood. 2022; 140:1925–1936 PubMed
Blumberg N, Cholette JM, Schmidt AE, et al. : Management of platelet disorders and platelet transfusions in ICU patients. Transfus Med Rev. 2017; 31:252–257 PubMed
Arnold DM, Crowther MA, Cook RJ, et al. : Utilization of platelet transfusions in the intensive care unit: Indications, transfusion triggers, and platelet count responses. Transfusion. 2006; 46:1286–1291 PubMed
Westbrook A, Pettila V, Nichol A, et al. ; Blood Observational Study Investigators of ANZICS-Clinical Trials Group: Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med. 2010; 36:1138–1146 PubMed
Stanworth SJ, Walsh TS, Prescott RJ, et al. ; Intensive Care Study of Coagulopathy Investigators: Thrombocytopenia and platelet transfusion in UK critical care: A multicenter observational study. Transfusion. 2013; 53:1050–1058 PubMed
Ning S, Barty R, Liu Y, et al. : Platelet transfusion practices in the ICU: Data from a large transfusion registry. Chest. 2016; 150:516–523 PubMed
Anthon CT, Pène F, Perner A, et al. : Thrombocytopenia and platelet transfusions in ICU patients: An international inception cohort study (PLOT-ICU). Intensive Care Med. 2023; 49:1327–1338 PubMed PMC
Holcomb JB, Tilley BC, Baraniuk S, et al. ; PROPPR Study Group: Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: The PROPPR randomized clinical trial. JAMA. 2015; 313:471–482 PubMed PMC
van Baarle FLF, van de Weerdt EK, van der Velden W, et al. : Platelet transfusion before CVC placement in patients with thrombocytopenia. N Engl J Med. 2023; 388:1956–1965 PubMed
Stanworth SJ, Estcourt LJ, Powter G, et al. ; TOPPS Investigators: A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med. 2013; 368:1771–1780 PubMed
Vlaar APJ, Dionne JC, de Bruin S, et al. : Transfusion strategies in bleeding critically ill adults: A clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. 2021; 47:1368–1392 PubMed PMC
Vlaar AP, Oczkowski S, de Bruin S, et al. : Transfusion strategies in non-bleeding critically ill adults: A clinical practice guideline from the European Society of Intensive Care Medicine. Intensive Care Med. 2020; 46:673–696 PubMed PMC
Metcalf RA, Nahirniak S, Guyatt G, et al. : Platelet transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines. JAMA. 2025; 334:606–617 PubMed
Kaufman RM, Djulbegovic B, Gernsheimer T, et al. ; AABB: Platelet transfusion: A clinical practice guideline from the AABB. Ann Intern Med. 2015; 162:205–213 PubMed
Estcourt LJ, Birchall J, Allard S, et al. ; British Committee for Standards in Haematology: Guidelines for the use of platelet transfusions. Br J Haematol. 2017; 176:365–394 PubMed
Peju E, Llitjos JF, Charpentier J, et al. : Impact of blood product transfusions on the risk of ICU-acquired infections in septic shock. Crit Care Med. 2021; 49:912–922 PubMed
Engele LJ, Straat M, van Rooijen IHM, et al. ; MARS Consortium: Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill. Ann Intensive Care. 2016; 6:67. PubMed PMC
Aubron C, Flint AW, Bailey M, et al. : Is platelet transfusion associated with hospital-acquired infections in critically ill patients? Crit Care. 2017; 21:2. PubMed PMC
Narayan S. (Ed) Poles D. et al. ; on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2021 Annual SHOT Report (2022).
Wandt H, Schaefer-Eckart K, Wendelin K, et al. ; Study Alliance Leukemia: Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: An open-label, multicentre, randomised study. Lancet. 2012; 380:1309–1316 PubMed
Warner MA, Chandran A, Frank RD, et al. : Prophylactic platelet transfusions for critically ill patients with thrombocytopenia: A single-institution propensity-matched cohort study. Anesth Analg. 2019; 128:288–295 PubMed PMC
Salman SS, Fernandez Perez ER, Stubbs JR, et al. : The practice of platelet transfusion in the intensive care unit. J Intensive Care Med. 2007; 22:105–110 PubMed
Schiffer CA, Bohlke K, Delaney M, et al. : Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2018; 36:283–299 PubMed
de Bruin S, Scheeren TWL, Bakker J, et al. : Transfusion practice in the non-bleeding critically ill: An international online survey—the TRACE survey. Crit Care. 2019; 23:309. PubMed PMC
de Bruin S, Eggermont D, van Bruggen R, et al. ; Cardiovascular Dynamics Section and Transfusion Task Force of the ESICM: Transfusion practice in the bleeding critically ill: An international online survey—the TRACE-2 survey. Transfusion. 2022; 62:324–335 PubMed PMC
Raasveld SJ, de Bruin S, Reuland MC, et al. ; InPUT Study Group: Red blood cell transfusion in the intensive care unit. JAMA. 2023; 330:1852–1861 PubMed PMC
The World Bank: World Bank Country and Lending Groups. Available at: https://data.worldbank.org/. Accessed August 28, 2023
Roberts N, James S, Delaney M, et al. : The global need and availability of blood products: A modelling study. Lancet Haematol. 2019; 6:e606–e615 PubMed
Roberts DJ, Field S, Delaney M, et al. : Problems and approaches for blood transfusion in the developing countries. Hematol Oncol Clin North Am. 2016; 30:477–495 PubMed
Custer B, Zou S, Glynn SA, et al. : Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: A NHLBI workshop. Transfusion. 2018; 58:1307–1317 PubMed PMC
Barnes LS, Stanley J, Bloch EM, et al. ; AABB Global Transfusion Forum: Status of hospital-based blood transfusion services in low-income and middle-income countries: A cross-sectional international survey. BMJ Open. 2022; 12:e055017 PubMed PMC
Warner MA, Shore-Lesserson L, Burns C: From product to patient-transfusion and patient blood management. JAMA. 2023; 330:1837–1838 PubMed